The odds ratio for presence of CRC compared to those without neoplasia was 25.9 (95% CI 17.3–38.4) for the multi-target assay (any gene positive) compared to 39.8 (95% CI 25.7–61.5) if using the ‘BCAT1 replicate rule’. This evidence concerns the gene BCAT1 and colorectal carcinoma.